182 related articles for article (PubMed ID: 20599413)
1. Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros).
Liozon E; Roussin C; Puéchal X; Garou A; Valadier P; Périnet I; Raffray L; Théry Y; De Lagarde B
Joint Bone Spine; 2011 Mar; 78(2):166-70. PubMed ID: 20599413
[TBL] [Abstract][Full Text] [Related]
2. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
[TBL] [Abstract][Full Text] [Related]
3. Behçet's disease in patients of west African and Afro-Caribbean origin.
Poon W; Verity DH; Larkin GL; Graham EM; Stanford MR
Br J Ophthalmol; 2003 Jul; 87(7):876-8. PubMed ID: 12812890
[TBL] [Abstract][Full Text] [Related]
4. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
[TBL] [Abstract][Full Text] [Related]
5. Case of elderly onset possible neuro-Behçet's disease with HLA-B51 homozygosity.
Shiraishi W; Tsujimoto Y; Matsuyoshi A; Hashimoto T
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37263675
[TBL] [Abstract][Full Text] [Related]
6. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
7. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients.
Kera J; Mizuki N; Ota M; Katsuyama Y; Pivetti-Pezzi P; Ohno S; Inoko H
Tissue Antigens; 1999 Dec; 54(6):565-71. PubMed ID: 10674970
[TBL] [Abstract][Full Text] [Related]
8. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
Arber N; Klein T; Meiner Z; Pras E; Weinberger A
Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078
[TBL] [Abstract][Full Text] [Related]
9. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.
Cohen R; Metzger S; Nahir M; Chajek-Shaul T
Ann Rheum Dis; 2002 Feb; 61(2):157-60. PubMed ID: 11796403
[TBL] [Abstract][Full Text] [Related]
10. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
[TBL] [Abstract][Full Text] [Related]
11. Primary association of HLA-B51 with Behçet's disease in Ireland.
Benezra D
Br J Ophthalmol; 1998 Jun; 82(6):715. PubMed ID: 9797683
[No Abstract] [Full Text] [Related]
12. Audio-vestibular disturbances in Behcet's patients: report of 62 cases.
Kulahli I; Balci K; Koseoglu E; Yuce I; Cagli S; Senturk M
Hear Res; 2005 May; 203(1-2):28-31. PubMed ID: 15855027
[TBL] [Abstract][Full Text] [Related]
13. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
[TBL] [Abstract][Full Text] [Related]
14. Primary association of HLA-B51 with Behçet's disease in Ireland.
Kilmartin DJ; Finch A; Acheson RW
Br J Ophthalmol; 1997 Aug; 81(8):649-53. PubMed ID: 9349151
[TBL] [Abstract][Full Text] [Related]
15. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
[TBL] [Abstract][Full Text] [Related]
16. Behçet's syndrome.
Yazici H; Yurdakul S; Hamuryudan V
Curr Opin Rheumatol; 1999 Jan; 11(1):53-7. PubMed ID: 9894631
[TBL] [Abstract][Full Text] [Related]
17. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
[TBL] [Abstract][Full Text] [Related]
18. Juvenile Behçet's disease: a tertiary center experience.
Ekici Tekin Z; Çelikel E; Aydin F; Kurt T; Sezer M; Tekgöz N; Karagöl C; Coşkun S; Kaplan MM; Çelikel Acar B
Clin Rheumatol; 2022 Jan; 41(1):187-194. PubMed ID: 34476647
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease in Western Switzerland: epidemiology and analysis of ocular involvement.
Ambresin A; Tran T; Spertini F; Herbort C
Ocul Immunol Inflamm; 2002 Mar; 10(1):53-63. PubMed ID: 12461704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
